792 related articles for article (PubMed ID: 19216064)
1. Allergen-specific immunotherapy in allergic rhinitis and asthma. Mechanisms and proof of efficacy.
Pipet A; Botturi K; Pinot D; Vervloet D; Magnan A
Respir Med; 2009 Jun; 103(6):800-12. PubMed ID: 19216064
[TBL] [Abstract][Full Text] [Related]
2. Multiallergen immunotherapy for allergic rhinitis and asthma.
Nelson HS
J Allergy Clin Immunol; 2009 Apr; 123(4):763-9. PubMed ID: 19217653
[TBL] [Abstract][Full Text] [Related]
3. One century of allergen-specific immunotherapy for respiratory allergy.
Incorvaia C; Frati F
Immunotherapy; 2011 May; 3(5):629-35. PubMed ID: 21554092
[TBL] [Abstract][Full Text] [Related]
4. [Vaccination with allergens in children].
Demoly P; Dhivert-Donnadieu H; Bousquet J
Allerg Immunol (Paris); 2000 Dec; 32(10):397-401. PubMed ID: 11209473
[TBL] [Abstract][Full Text] [Related]
5. Sublingual immunotherapy for children: Are we there yet? Defining its role in clinical practice.
Campbell DE
Paediatr Respir Rev; 2009 Jun; 10(2):69-74; quiz 74. PubMed ID: 19410205
[TBL] [Abstract][Full Text] [Related]
6. Specific allergy immunotherapy for allergic rhinitis: subcutaneous and sublingual.
Cox L; Wallace D
Immunol Allergy Clin North Am; 2011 Aug; 31(3):561-99. PubMed ID: 21737043
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous versus sublingual immunotherapy for allergic rhinitis and/or asthma.
Bahceciler NN; Cobanoglu N
Immunotherapy; 2011 Jun; 3(6):747-56. PubMed ID: 21668312
[TBL] [Abstract][Full Text] [Related]
8. Sublingual immunotherapy in the treatment of adult allergic rhinitis patients.
Canonica GW; Passalacqua G
Allergy; 2006; 61 Suppl 81():20-3. PubMed ID: 16792602
[TBL] [Abstract][Full Text] [Related]
9. [The value and possibilities of immunotherapy in the treatment of allergic rhinitis].
Pfaar O; Hörmann K; Klimek L
MMW Fortschr Med; 2006 Feb; 148(5):28-32. PubMed ID: 16518935
[TBL] [Abstract][Full Text] [Related]
10. How to design and evaluate randomized controlled trials in immunotherapy for allergic rhinitis: an ARIA-GA(2) LEN statement.
Bousquet J; Schünemann HJ; Bousquet PJ; Bachert C; Canonica GW; Casale TB; Demoly P; Durham S; Carlsen KH; Malling HJ; Passalacqua G; Simons FE; Anto J; Baena-Cagnani CE; Bergmann KC; Bieber T; Briggs AH; Brozek J; Calderon MA; Dahl R; Devillier P; Gerth van Wijk R; Howarth P; Larenas D; Papadopoulos NG; Schmid-Grendelmeier P; Zuberbier T
Allergy; 2011 Jun; 66(6):765-74. PubMed ID: 21496059
[TBL] [Abstract][Full Text] [Related]
11. [Preventive immunotherapy].
Boquete M; Carballada F; Expósito F; González A
Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
[TBL] [Abstract][Full Text] [Related]
12. Evidence-based practice: sublingual immunotherapy for allergic rhinitis.
Wise SK; Schlosser RJ
Otolaryngol Clin North Am; 2012 Oct; 45(5):1045-54. PubMed ID: 22980684
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of sublingual immunotherapy.
Scadding G; Durham S
J Asthma; 2009 May; 46(4):322-34. PubMed ID: 19484663
[TBL] [Abstract][Full Text] [Related]
14. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses.
Compalati E; Penagos M; Tarantini F; Passalacqua G; Canonica GW
Ann Allergy Asthma Immunol; 2009 Jan; 102(1):22-8. PubMed ID: 19205281
[TBL] [Abstract][Full Text] [Related]
15. Meta-analyses of specific immunotherapy trials.
Calderon MA
Drugs Today (Barc); 2008 Dec; 44 Suppl B():31-4. PubMed ID: 19221615
[No Abstract] [Full Text] [Related]
16. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
17. Multiallergen-specific immunotherapy in polysensitized patients: where are we?
Bahceciler NN; Galip N; Cobanoglu N
Immunotherapy; 2013 Feb; 5(2):183-90. PubMed ID: 23413909
[TBL] [Abstract][Full Text] [Related]
18. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
Cochard MM; Eigenmann PA
J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
[No Abstract] [Full Text] [Related]
19. New visions in specific immunotherapy in children: an iPAC summary and future trends.
Halken S; Lau S; Valovirta E
Pediatr Allergy Immunol; 2008 Aug; 19 Suppl 19():60-70. PubMed ID: 18665964
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
